nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—CYP3A4—Thiotepa—sarcoma	0.137	0.191	CbGbCtD
Mirabegron—ABCB1—Dactinomycin—sarcoma	0.11	0.153	CbGbCtD
Mirabegron—ABCB1—Mitoxantrone—sarcoma	0.0985	0.137	CbGbCtD
Mirabegron—ABCB1—Vincristine—sarcoma	0.0678	0.0941	CbGbCtD
Mirabegron—ABCB1—Etoposide—sarcoma	0.0621	0.0862	CbGbCtD
Mirabegron—CYP3A4—Mitoxantrone—sarcoma	0.059	0.0819	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—sarcoma	0.0423	0.0588	CbGbCtD
Mirabegron—CYP3A4—Vincristine—sarcoma	0.0406	0.0564	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—sarcoma	0.0399	0.0554	CbGbCtD
Mirabegron—CYP3A4—Etoposide—sarcoma	0.0372	0.0517	CbGbCtD
Mirabegron—CYP3A4—Doxorubicin—sarcoma	0.0254	0.0352	CbGbCtD
Mirabegron—BCHE—diaphragm—sarcoma	0.00661	0.245	CbGeAlD
Mirabegron—Gamma-glutamyltransferase increased—Thiotepa—sarcoma	0.0043	0.017	CcSEcCtD
Mirabegron—Rash papular—Epirubicin—sarcoma	0.00382	0.0151	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Mitoxantrone—sarcoma	0.00371	0.0147	CcSEcCtD
Mirabegron—Rash papular—Doxorubicin—sarcoma	0.00354	0.014	CcSEcCtD
Mirabegron—Cystitis noninfective—Thiotepa—sarcoma	0.00346	0.0137	CcSEcCtD
Mirabegron—Cystitis—Thiotepa—sarcoma	0.00342	0.0135	CcSEcCtD
Mirabegron—Bladder pain—Thiotepa—sarcoma	0.0032	0.0126	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Epirubicin—sarcoma	0.00278	0.011	CcSEcCtD
Mirabegron—Lactic dehydrogenase activity increased—Doxorubicin—sarcoma	0.00258	0.0102	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Epirubicin—sarcoma	0.00245	0.00969	CcSEcCtD
Mirabegron—Urinary retention—Thiotepa—sarcoma	0.00244	0.00965	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00231	0.00914	CcSEcCtD
Mirabegron—ADRB3—connective tissue—sarcoma	0.00231	0.0856	CbGeAlD
Mirabegron—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.0023	0.00907	CcSEcCtD
Mirabegron—Blood lactate dehydrogenase increased—Doxorubicin—sarcoma	0.00227	0.00896	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00226	0.00895	CcSEcCtD
Mirabegron—Urinary retention—Vincristine—sarcoma	0.00217	0.00856	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Vincristine—sarcoma	0.00205	0.00811	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.002	0.00789	CcSEcCtD
Mirabegron—Infestation—Thiotepa—sarcoma	0.00198	0.00782	CcSEcCtD
Mirabegron—Infestation NOS—Thiotepa—sarcoma	0.00198	0.00782	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00196	0.00773	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00195	0.0077	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00178	0.00704	CcSEcCtD
Mirabegron—Urinary tract disorder—Thiotepa—sarcoma	0.00175	0.00694	CcSEcCtD
Mirabegron—Connective tissue disorder—Thiotepa—sarcoma	0.00175	0.0069	CcSEcCtD
Mirabegron—Urethral disorder—Thiotepa—sarcoma	0.00174	0.00688	CcSEcCtD
Mirabegron—Erythema multiforme—Dactinomycin—sarcoma	0.00167	0.00659	CcSEcCtD
Mirabegron—Urinary tract infection—Mitoxantrone—sarcoma	0.00166	0.00657	CcSEcCtD
Mirabegron—Eye disorder—Thiotepa—sarcoma	0.00166	0.00656	CcSEcCtD
Mirabegron—Cardiac disorder—Thiotepa—sarcoma	0.00165	0.00652	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Etoposide—sarcoma	0.00163	0.00643	CcSEcCtD
Mirabegron—Sinusitis—Mitoxantrone—sarcoma	0.0016	0.00634	CcSEcCtD
Mirabegron—ALB—mammary gland—sarcoma	0.0016	0.0593	CbGeAlD
Mirabegron—Urinary tract disorder—Vincristine—sarcoma	0.00156	0.00615	CcSEcCtD
Mirabegron—Connective tissue disorder—Vincristine—sarcoma	0.00155	0.00612	CcSEcCtD
Mirabegron—Urethral disorder—Vincristine—sarcoma	0.00154	0.0061	CcSEcCtD
Mirabegron—Rhinitis—Mitoxantrone—sarcoma	0.00154	0.00608	CcSEcCtD
Mirabegron—Back pain—Thiotepa—sarcoma	0.0015	0.00591	CcSEcCtD
Mirabegron—Cardiac disorder—Vincristine—sarcoma	0.00146	0.00578	CcSEcCtD
Mirabegron—Vision blurred—Thiotepa—sarcoma	0.00146	0.00576	CcSEcCtD
Mirabegron—Infestation—Etoposide—sarcoma	0.00142	0.00562	CcSEcCtD
Mirabegron—Infestation NOS—Etoposide—sarcoma	0.00142	0.00562	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00141	0.00557	CcSEcCtD
Mirabegron—Cystitis noninfective—Epirubicin—sarcoma	0.00139	0.0055	CcSEcCtD
Mirabegron—Cystitis—Epirubicin—sarcoma	0.00138	0.00544	CcSEcCtD
Mirabegron—Vaginal infection—Epirubicin—sarcoma	0.00134	0.00532	CcSEcCtD
Mirabegron—Hypertension—Thiotepa—sarcoma	0.00134	0.00528	CcSEcCtD
Mirabegron—Back pain—Vincristine—sarcoma	0.00133	0.00524	CcSEcCtD
Mirabegron—Arthralgia—Thiotepa—sarcoma	0.00132	0.0052	CcSEcCtD
Mirabegron—Dry eye—Epirubicin—sarcoma	0.00132	0.0052	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00131	0.00517	CcSEcCtD
Mirabegron—Back pain—Mitoxantrone—sarcoma	0.00129	0.00511	CcSEcCtD
Mirabegron—Neoplasm—Epirubicin—sarcoma	0.00129	0.00509	CcSEcCtD
Mirabegron—Bladder pain—Epirubicin—sarcoma	0.00129	0.00509	CcSEcCtD
Mirabegron—Cystitis noninfective—Doxorubicin—sarcoma	0.00129	0.00509	CcSEcCtD
Mirabegron—Cystitis—Doxorubicin—sarcoma	0.00127	0.00503	CcSEcCtD
Mirabegron—Urinary tract disorder—Etoposide—sarcoma	0.00126	0.00498	CcSEcCtD
Mirabegron—Vision blurred—Mitoxantrone—sarcoma	0.00126	0.00498	CcSEcCtD
Mirabegron—Infection—Thiotepa—sarcoma	0.00125	0.00496	CcSEcCtD
Mirabegron—Urethral disorder—Etoposide—sarcoma	0.00125	0.00494	CcSEcCtD
Mirabegron—Infection—Dactinomycin—sarcoma	0.00124	0.00492	CcSEcCtD
Mirabegron—Vaginal infection—Doxorubicin—sarcoma	0.00124	0.00492	CcSEcCtD
Mirabegron—Tachycardia—Thiotepa—sarcoma	0.00123	0.00487	CcSEcCtD
Mirabegron—Skin disorder—Thiotepa—sarcoma	0.00123	0.00485	CcSEcCtD
Mirabegron—Dry eye—Doxorubicin—sarcoma	0.00122	0.00481	CcSEcCtD
Mirabegron—Erythema multiforme—Etoposide—sarcoma	0.00121	0.00477	CcSEcCtD
Mirabegron—Eye disorder—Etoposide—sarcoma	0.00119	0.00471	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—sarcoma	0.00119	0.00471	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—sarcoma	0.00119	0.00471	CcSEcCtD
Mirabegron—Cardiac disorder—Etoposide—sarcoma	0.00118	0.00468	CcSEcCtD
Mirabegron—Hypertension—Vincristine—sarcoma	0.00118	0.00468	CcSEcCtD
Mirabegron—Vascular purpura—Epirubicin—sarcoma	0.00116	0.00457	CcSEcCtD
Mirabegron—Hypertension—Mitoxantrone—sarcoma	0.00115	0.00456	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00115	0.00455	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00114	0.00451	CcSEcCtD
Mirabegron—Arthralgia—Mitoxantrone—sarcoma	0.00114	0.00449	CcSEcCtD
Mirabegron—ORM1—hematopoietic system—sarcoma	0.00111	0.0412	CbGeAlD
Mirabegron—Infection—Vincristine—sarcoma	0.00111	0.0044	CcSEcCtD
Mirabegron—Dyspepsia—Thiotepa—sarcoma	0.00111	0.00439	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Thiotepa—sarcoma	0.00109	0.00431	CcSEcCtD
Mirabegron—Fatigue—Thiotepa—sarcoma	0.00109	0.0043	CcSEcCtD
Mirabegron—Infection—Mitoxantrone—sarcoma	0.00108	0.00428	CcSEcCtD
Mirabegron—Fatigue—Dactinomycin—sarcoma	0.00108	0.00427	CcSEcCtD
Mirabegron—Constipation—Thiotepa—sarcoma	0.00108	0.00427	CcSEcCtD
Mirabegron—Back pain—Etoposide—sarcoma	0.00107	0.00425	CcSEcCtD
Mirabegron—Purpura—Epirubicin—sarcoma	0.00107	0.00424	CcSEcCtD
Mirabegron—Vascular purpura—Doxorubicin—sarcoma	0.00107	0.00423	CcSEcCtD
Mirabegron—Tachycardia—Mitoxantrone—sarcoma	0.00106	0.00421	CcSEcCtD
Mirabegron—Skin disorder—Mitoxantrone—sarcoma	0.00106	0.00419	CcSEcCtD
Mirabegron—Cerebrovascular accident—Epirubicin—sarcoma	0.00106	0.00417	CcSEcCtD
Mirabegron—Osteoarthritis—Epirubicin—sarcoma	0.00103	0.00409	CcSEcCtD
Mirabegron—Gastrointestinal pain—Thiotepa—sarcoma	0.00103	0.00408	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dactinomycin—sarcoma	0.00102	0.00405	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Vincristine—sarcoma	0.00102	0.00403	CcSEcCtD
Mirabegron—Urticaria—Thiotepa—sarcoma	0.001	0.00396	CcSEcCtD
Mirabegron—Abdominal pain—Thiotepa—sarcoma	0.000998	0.00394	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000993	0.00393	CcSEcCtD
Mirabegron—Purpura—Doxorubicin—sarcoma	0.000993	0.00392	CcSEcCtD
Mirabegron—Abdominal pain—Dactinomycin—sarcoma	0.00099	0.00391	CcSEcCtD
Mirabegron—SLCO1A2—hematopoietic system—sarcoma	0.000982	0.0364	CbGeAlD
Mirabegron—Cerebrovascular accident—Doxorubicin—sarcoma	0.000976	0.00386	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Vincristine—sarcoma	0.000966	0.00382	CcSEcCtD
Mirabegron—Fatigue—Vincristine—sarcoma	0.000965	0.00381	CcSEcCtD
Mirabegron—Dyspepsia—Mitoxantrone—sarcoma	0.000959	0.00379	CcSEcCtD
Mirabegron—Hypertension—Etoposide—sarcoma	0.000959	0.00379	CcSEcCtD
Mirabegron—Constipation—Vincristine—sarcoma	0.000957	0.00378	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—sarcoma	0.000957	0.00378	CcSEcCtD
Mirabegron—Fatigue—Mitoxantrone—sarcoma	0.00094	0.00371	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000939	0.00371	CcSEcCtD
Mirabegron—Breast disorder—Epirubicin—sarcoma	0.000934	0.00369	CcSEcCtD
Mirabegron—Constipation—Mitoxantrone—sarcoma	0.000932	0.00368	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000931	0.00368	CcSEcCtD
Mirabegron—Nasopharyngitis—Epirubicin—sarcoma	0.000925	0.00366	CcSEcCtD
Mirabegron—Gastrointestinal pain—Vincristine—sarcoma	0.000915	0.00362	CcSEcCtD
Mirabegron—Gastritis—Epirubicin—sarcoma	0.000915	0.00362	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000912	0.0036	CcSEcCtD
Mirabegron—Asthenia—Thiotepa—sarcoma	0.000906	0.00358	CcSEcCtD
Mirabegron—Infection—Etoposide—sarcoma	0.000901	0.00356	CcSEcCtD
Mirabegron—Abdominal distension—Epirubicin—sarcoma	0.0009	0.00356	CcSEcCtD
Mirabegron—Asthenia—Dactinomycin—sarcoma	0.000899	0.00355	CcSEcCtD
Mirabegron—Influenza—Epirubicin—sarcoma	0.000894	0.00353	CcSEcCtD
Mirabegron—Pruritus—Thiotepa—sarcoma	0.000893	0.00353	CcSEcCtD
Mirabegron—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000891	0.00352	CcSEcCtD
Mirabegron—Tachycardia—Etoposide—sarcoma	0.000885	0.0035	CcSEcCtD
Mirabegron—Abdominal pain—Vincristine—sarcoma	0.000885	0.0035	CcSEcCtD
Mirabegron—Skin disorder—Etoposide—sarcoma	0.000881	0.00348	CcSEcCtD
Mirabegron—Urticaria—Mitoxantrone—sarcoma	0.000866	0.00342	CcSEcCtD
Mirabegron—Breast disorder—Doxorubicin—sarcoma	0.000865	0.00342	CcSEcCtD
Mirabegron—Diarrhoea—Thiotepa—sarcoma	0.000864	0.00341	CcSEcCtD
Mirabegron—Abdominal pain—Mitoxantrone—sarcoma	0.000862	0.00341	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000862	0.00341	CcSEcCtD
Mirabegron—Diarrhoea—Dactinomycin—sarcoma	0.000857	0.00339	CcSEcCtD
Mirabegron—Nasopharyngitis—Doxorubicin—sarcoma	0.000856	0.00338	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—sarcoma	0.000847	0.00335	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000844	0.00334	CcSEcCtD
Mirabegron—Dizziness—Thiotepa—sarcoma	0.000835	0.0033	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—sarcoma	0.000832	0.00329	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Epirubicin—sarcoma	0.000831	0.00328	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—sarcoma	0.000827	0.00327	CcSEcCtD
Mirabegron—BCHE—myometrium—sarcoma	0.000804	0.0298	CbGeAlD
Mirabegron—Asthenia—Vincristine—sarcoma	0.000803	0.00317	CcSEcCtD
Mirabegron—Infestation—Epirubicin—sarcoma	0.000797	0.00315	CcSEcCtD
Mirabegron—Infestation NOS—Epirubicin—sarcoma	0.000797	0.00315	CcSEcCtD
Mirabegron—Rash—Thiotepa—sarcoma	0.000796	0.00315	CcSEcCtD
Mirabegron—Dermatitis—Thiotepa—sarcoma	0.000795	0.00314	CcSEcCtD
Mirabegron—Headache—Thiotepa—sarcoma	0.000791	0.00313	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00079	0.00312	CcSEcCtD
Mirabegron—Rash—Dactinomycin—sarcoma	0.00079	0.00312	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Etoposide—sarcoma	0.000783	0.00309	CcSEcCtD
Mirabegron—Asthenia—Mitoxantrone—sarcoma	0.000782	0.00309	CcSEcCtD
Mirabegron—Fatigue—Etoposide—sarcoma	0.000782	0.00309	CcSEcCtD
Mirabegron—Constipation—Etoposide—sarcoma	0.000775	0.00306	CcSEcCtD
Mirabegron—Urinary tract infection—Epirubicin—sarcoma	0.000775	0.00306	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000769	0.00304	CcSEcCtD
Mirabegron—Diarrhoea—Vincristine—sarcoma	0.000766	0.00303	CcSEcCtD
Mirabegron—Nausea—Thiotepa—sarcoma	0.00075	0.00296	CcSEcCtD
Mirabegron—Sinusitis—Epirubicin—sarcoma	0.000748	0.00296	CcSEcCtD
Mirabegron—Diarrhoea—Mitoxantrone—sarcoma	0.000746	0.00295	CcSEcCtD
Mirabegron—Nausea—Dactinomycin—sarcoma	0.000744	0.00294	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etoposide—sarcoma	0.000741	0.00293	CcSEcCtD
Mirabegron—Dizziness—Vincristine—sarcoma	0.00074	0.00293	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—sarcoma	0.000737	0.00291	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—sarcoma	0.000737	0.00291	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000731	0.00289	CcSEcCtD
Mirabegron—BCHE—seminal vesicle—sarcoma	0.000726	0.0269	CbGeAlD
Mirabegron—Urticaria—Etoposide—sarcoma	0.00072	0.00285	CcSEcCtD
Mirabegron—Rhinitis—Epirubicin—sarcoma	0.000717	0.00283	CcSEcCtD
Mirabegron—Abdominal pain—Etoposide—sarcoma	0.000717	0.00283	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—sarcoma	0.000717	0.00283	CcSEcCtD
Mirabegron—ORM1—bone marrow—sarcoma	0.000714	0.0264	CbGeAlD
Mirabegron—Urinary tract disorder—Epirubicin—sarcoma	0.000706	0.00279	CcSEcCtD
Mirabegron—Rash—Vincristine—sarcoma	0.000706	0.00279	CcSEcCtD
Mirabegron—Dermatitis—Vincristine—sarcoma	0.000705	0.00279	CcSEcCtD
Mirabegron—Connective tissue disorder—Epirubicin—sarcoma	0.000703	0.00278	CcSEcCtD
Mirabegron—Urethral disorder—Epirubicin—sarcoma	0.000701	0.00277	CcSEcCtD
Mirabegron—Headache—Vincristine—sarcoma	0.000701	0.00277	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—sarcoma	0.000692	0.00273	CcSEcCtD
Mirabegron—BCHE—hematopoietic system—sarcoma	0.00069	0.0256	CbGeAlD
Mirabegron—Rash—Mitoxantrone—sarcoma	0.000687	0.00272	CcSEcCtD
Mirabegron—Dermatitis—Mitoxantrone—sarcoma	0.000687	0.00271	CcSEcCtD
Mirabegron—Headache—Mitoxantrone—sarcoma	0.000683	0.0027	CcSEcCtD
Mirabegron—Erythema multiforme—Epirubicin—sarcoma	0.000676	0.00267	CcSEcCtD
Mirabegron—Eye disorder—Epirubicin—sarcoma	0.000669	0.00264	CcSEcCtD
Mirabegron—Nausea—Vincristine—sarcoma	0.000665	0.00263	CcSEcCtD
Mirabegron—Cardiac disorder—Epirubicin—sarcoma	0.000664	0.00262	CcSEcCtD
Mirabegron—Rhinitis—Doxorubicin—sarcoma	0.000664	0.00262	CcSEcCtD
Mirabegron—Urinary tract disorder—Doxorubicin—sarcoma	0.000654	0.00258	CcSEcCtD
Mirabegron—Asthenia—Etoposide—sarcoma	0.00065	0.00257	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—sarcoma	0.00065	0.00257	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—sarcoma	0.000649	0.00256	CcSEcCtD
Mirabegron—Nausea—Mitoxantrone—sarcoma	0.000647	0.00256	CcSEcCtD
Mirabegron—Pruritus—Etoposide—sarcoma	0.000641	0.00254	CcSEcCtD
Mirabegron—Erythema multiforme—Doxorubicin—sarcoma	0.000626	0.00247	CcSEcCtD
Mirabegron—Diarrhoea—Etoposide—sarcoma	0.00062	0.00245	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—sarcoma	0.000619	0.00245	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—sarcoma	0.000614	0.00243	CcSEcCtD
Mirabegron—BCHE—smooth muscle tissue—sarcoma	0.000608	0.0225	CbGeAlD
Mirabegron—Back pain—Epirubicin—sarcoma	0.000602	0.00238	CcSEcCtD
Mirabegron—BCHE—skin of body—sarcoma	0.0006	0.0222	CbGeAlD
Mirabegron—Dizziness—Etoposide—sarcoma	0.0006	0.00237	CcSEcCtD
Mirabegron—Vision blurred—Epirubicin—sarcoma	0.000587	0.00232	CcSEcCtD
Mirabegron—ORM1—liver—sarcoma	0.000577	0.0214	CbGeAlD
Mirabegron—Rash—Etoposide—sarcoma	0.000572	0.00226	CcSEcCtD
Mirabegron—Dermatitis—Etoposide—sarcoma	0.000571	0.00226	CcSEcCtD
Mirabegron—Headache—Etoposide—sarcoma	0.000568	0.00225	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—sarcoma	0.000557	0.0022	CcSEcCtD
Mirabegron—Palpitations—Epirubicin—sarcoma	0.00055	0.00218	CcSEcCtD
Mirabegron—Vision blurred—Doxorubicin—sarcoma	0.000543	0.00215	CcSEcCtD
Mirabegron—Nausea—Etoposide—sarcoma	0.000539	0.00213	CcSEcCtD
Mirabegron—SLCO1A2—testis—sarcoma	0.000538	0.0199	CbGeAlD
Mirabegron—Hypertension—Epirubicin—sarcoma	0.000538	0.00213	CcSEcCtD
Mirabegron—ALB—testis—sarcoma	0.000535	0.0198	CbGeAlD
Mirabegron—Arthralgia—Epirubicin—sarcoma	0.00053	0.0021	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000526	0.00208	CcSEcCtD
Mirabegron—BCHE—cardiac atrium—sarcoma	0.000524	0.0194	CbGeAlD
Mirabegron—BCHE—uterus—sarcoma	0.000521	0.0193	CbGeAlD
Mirabegron—Dry mouth—Epirubicin—sarcoma	0.000518	0.00205	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—sarcoma	0.000509	0.00201	CcSEcCtD
Mirabegron—SLCO1A2—liver—sarcoma	0.000509	0.0188	CbGeAlD
Mirabegron—ALB—liver—sarcoma	0.000506	0.0187	CbGeAlD
Mirabegron—Infection—Epirubicin—sarcoma	0.000505	0.002	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—sarcoma	0.000497	0.00197	CcSEcCtD
Mirabegron—Tachycardia—Epirubicin—sarcoma	0.000496	0.00196	CcSEcCtD
Mirabegron—Skin disorder—Epirubicin—sarcoma	0.000494	0.00195	CcSEcCtD
Mirabegron—Arthralgia—Doxorubicin—sarcoma	0.000491	0.00194	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000487	0.00193	CcSEcCtD
Mirabegron—Dry mouth—Doxorubicin—sarcoma	0.00048	0.0019	CcSEcCtD
Mirabegron—Infection—Doxorubicin—sarcoma	0.000467	0.00185	CcSEcCtD
Mirabegron—CYP3A4—hematopoietic system—sarcoma	0.000465	0.0172	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000463	0.00183	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—sarcoma	0.000459	0.00181	CcSEcCtD
Mirabegron—CYP2D6—hematopoietic system—sarcoma	0.000457	0.0169	CbGeAlD
Mirabegron—Skin disorder—Doxorubicin—sarcoma	0.000457	0.00181	CcSEcCtD
Mirabegron—Dyspepsia—Epirubicin—sarcoma	0.000447	0.00177	CcSEcCtD
Mirabegron—BCHE—bone marrow—sarcoma	0.000442	0.0164	CbGeAlD
Mirabegron—ORM1—lymph node—sarcoma	0.000442	0.0164	CbGeAlD
Mirabegron—Gastrointestinal disorder—Epirubicin—sarcoma	0.000439	0.00173	CcSEcCtD
Mirabegron—Fatigue—Epirubicin—sarcoma	0.000438	0.00173	CcSEcCtD
Mirabegron—Constipation—Epirubicin—sarcoma	0.000435	0.00172	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000428	0.00169	CcSEcCtD
Mirabegron—Gastrointestinal pain—Epirubicin—sarcoma	0.000416	0.00164	CcSEcCtD
Mirabegron—Dyspepsia—Doxorubicin—sarcoma	0.000414	0.00164	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000406	0.0016	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—sarcoma	0.000405	0.0016	CcSEcCtD
Mirabegron—Urticaria—Epirubicin—sarcoma	0.000404	0.0016	CcSEcCtD
Mirabegron—Constipation—Doxorubicin—sarcoma	0.000402	0.00159	CcSEcCtD
Mirabegron—Abdominal pain—Epirubicin—sarcoma	0.000402	0.00159	CcSEcCtD
Mirabegron—ALB—lymph node—sarcoma	0.000388	0.0144	CbGeAlD
Mirabegron—Gastrointestinal pain—Doxorubicin—sarcoma	0.000385	0.00152	CcSEcCtD
Mirabegron—ABCB1—myometrium—sarcoma	0.000383	0.0142	CbGeAlD
Mirabegron—BCHE—testis—sarcoma	0.000378	0.014	CbGeAlD
Mirabegron—Urticaria—Doxorubicin—sarcoma	0.000374	0.00148	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—sarcoma	0.000372	0.00147	CcSEcCtD
Mirabegron—ABCB1—embryo—sarcoma	0.000368	0.0136	CbGeAlD
Mirabegron—Asthenia—Epirubicin—sarcoma	0.000365	0.00144	CcSEcCtD
Mirabegron—Pruritus—Epirubicin—sarcoma	0.00036	0.00142	CcSEcCtD
Mirabegron—BCHE—liver—sarcoma	0.000358	0.0132	CbGeAlD
Mirabegron—Diarrhoea—Epirubicin—sarcoma	0.000348	0.00137	CcSEcCtD
Mirabegron—ABCB1—seminal vesicle—sarcoma	0.000346	0.0128	CbGeAlD
Mirabegron—Asthenia—Doxorubicin—sarcoma	0.000337	0.00133	CcSEcCtD
Mirabegron—Dizziness—Epirubicin—sarcoma	0.000336	0.00133	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—sarcoma	0.000333	0.00132	CcSEcCtD
Mirabegron—ABCB1—hematopoietic system—sarcoma	0.000329	0.0122	CbGeAlD
Mirabegron—Diarrhoea—Doxorubicin—sarcoma	0.000322	0.00127	CcSEcCtD
Mirabegron—Rash—Epirubicin—sarcoma	0.00032	0.00127	CcSEcCtD
Mirabegron—Dermatitis—Epirubicin—sarcoma	0.00032	0.00127	CcSEcCtD
Mirabegron—Headache—Epirubicin—sarcoma	0.000318	0.00126	CcSEcCtD
Mirabegron—Dizziness—Doxorubicin—sarcoma	0.000311	0.00123	CcSEcCtD
Mirabegron—Nausea—Epirubicin—sarcoma	0.000302	0.00119	CcSEcCtD
Mirabegron—Rash—Doxorubicin—sarcoma	0.000296	0.00117	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—sarcoma	0.000296	0.00117	CcSEcCtD
Mirabegron—Headache—Doxorubicin—sarcoma	0.000295	0.00116	CcSEcCtD
Mirabegron—Nausea—Doxorubicin—sarcoma	0.000279	0.0011	CcSEcCtD
Mirabegron—BCHE—lymph node—sarcoma	0.000274	0.0102	CbGeAlD
Mirabegron—CYP2D6—testis—sarcoma	0.000251	0.00928	CbGeAlD
Mirabegron—ABCB1—uterus—sarcoma	0.000248	0.0092	CbGeAlD
Mirabegron—CYP3A4—liver—sarcoma	0.000241	0.00891	CbGeAlD
Mirabegron—CYP2D6—liver—sarcoma	0.000237	0.00877	CbGeAlD
Mirabegron—ABCB1—lymphoid tissue—sarcoma	0.000232	0.00857	CbGeAlD
Mirabegron—ABCB1—bone marrow—sarcoma	0.000211	0.00781	CbGeAlD
Mirabegron—ABCB1—testis—sarcoma	0.00018	0.00667	CbGeAlD
Mirabegron—ABCB1—liver—sarcoma	0.00017	0.00631	CbGeAlD
Mirabegron—ABCB1—lymph node—sarcoma	0.000131	0.00484	CbGeAlD
